[1]
K. Stępień and G. Gajos, “Modern antithrombotic treatment in patients with atherosclerotic cardiovascular diseases. The position of rivaroxaban in current guidelines and everyday clinical practice”, J EBM, vol. 17, no. 1(62), pp. 43-50, Mar. 2024.